These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 8510319

  • 1. [Enhancement of in vitro antimicrobial activity of cefmetazole and cefotiam in combination against methicillin-susceptible and -resistant Staphylococcus aureus studied using checkerboard MIC method and disc diffusion method with discs containing both drugs].
    Matsuo K, Uete T.
    Jpn J Antibiot; 1993 Mar; 46(3):222-33. PubMed ID: 8510319
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Synergistic enhancement of in vitro antimicrobial activity of cefmetazole and cefazolin, cefotiam, cefamandole or cefoperazone in combination against methicillin-sensitive and -resistant Staphylococcus aureus. I. Effect of NaCl.
    Uete T, Matsuo K.
    Jpn J Antibiot; 1995 Apr; 48(4):553-62. PubMed ID: 7783318
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Antimicrobial activity of fosfomycin against beta-lactamase-producing methicillin-sensitive Staphylococcus aureus and methicillin-sensitive coagulase-negative staphylococci].
    Hara T, Araake M, Tsuruoka T, Watabe H.
    Jpn J Antibiot; 2003 Apr; 56(2):142-7. PubMed ID: 12825415
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Bacteriological evaluations of combination therapies with minocycline and beta-lactams for methicillin-resistant Staphylococcus aureus. I. Cefotiam plus minocycline].
    Deguchi K, Yokota N, Koguchi M, Nakane Y, Suzuki Y, Fukayama S, Ishihara R.
    Jpn J Antibiot; 1992 Jun; 45(6):597-604. PubMed ID: 1507393
    [Abstract] [Full Text] [Related]

  • 12. [Comparison of in vitro activity of first, second and third generation cephem antibiotics against various pathogens isolated from clinical materials in 1983].
    Matsuo K, Tsuzaki Y, Furukawa S, Uete T.
    Jpn J Antibiot; 1984 Jun; 37(6):1040-57. PubMed ID: 6387213
    [Abstract] [Full Text] [Related]

  • 13. [Bacteriological evaluations of combination effects with cefotiam and other antimicrobial agents against methicillin-resistant Staphylococcus aureus. II. Synergistic actions of cefotiam with arbekacin and minocycline].
    Deguchi K, Yokota N, Koguchi M, Suzuki Y, Suzuki K, Fukayama S, Ishihara R.
    Jpn J Antibiot; 1993 Feb; 46(2):123-9. PubMed ID: 8331772
    [Abstract] [Full Text] [Related]

  • 14. [Antibacterial activity of imipenem in combination with ampicillin against methicillin-resistant strains of Staphylococcus aureus].
    Saionji K, Shitara M, Miyake N, Inoue K, Kobayashi I.
    Jpn J Antibiot; 1990 Oct; 43(10):1685-97. PubMed ID: 2086811
    [Abstract] [Full Text] [Related]

  • 15. [Antibacterial activities of combination uses of isepamicin and beta-lactams in vitro against clinically isolated strains. Part 1. Activities against Staphylococcus aureus].
    Deguchi K, Koguchi M, Suzuki Y, Tanaka S, Fukayama S, Ishihara R, Oda S.
    Jpn J Antibiot; 1996 Feb; 49(2):194-202. PubMed ID: 8721079
    [Abstract] [Full Text] [Related]

  • 16. [Clinical laboratory approach for estimating the effective administrative dose of latamoxef. Significance of a 4-category system interpretation of the latamoxef disc susceptibility test].
    Uete T, Matsuo K.
    Jpn J Antibiot; 1987 Nov; 40(11):1906-16. PubMed ID: 3327966
    [Abstract] [Full Text] [Related]

  • 17. [Surveillance of susceptibility of clinical isolates to cefmetazole between 2000 and 2003].
    Sato Y, Abe T, Koga T, Ito K, Tochikawa Y.
    Jpn J Antibiot; 2005 Jun; 58(3):303-16. PubMed ID: 16161756
    [Abstract] [Full Text] [Related]

  • 18. The effect of combinations of cefotiam and other antibiotics on methicillin-resistant Staphylococcus aureus in vitro.
    Sugiura A, Jono K, Kono T, Higashide E.
    J Antimicrob Chemother; 1991 Nov; 28(5):707-17. PubMed ID: 1778874
    [Abstract] [Full Text] [Related]

  • 19. [Clinical laboratory approach for estimating effective administrative dose of sulbactam/cefoperazone].
    Uete T, Matsuo K.
    Jpn J Antibiot; 1988 Nov; 41(11):1578-90. PubMed ID: 3210296
    [Abstract] [Full Text] [Related]

  • 20. Combination chemotherapy for infections due to methicillin-resistant Staphylococcus aureus with combination therapy by cefuzonam and fosfomycin or minocycline in the urologic field.
    Matsumoto T, Kubo S, Haraoka M, Takahashi K, Tanaka M, Sakumoto M, Kumazawa J.
    Clin Ther; 1993 Nov; 15(5):819-28. PubMed ID: 8269448
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.